These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25582751)

  • 21. Population-based analysis of BAP1 germline variations in patients with uveal melanoma.
    Repo P; Järvinen RS; Jäntti JE; Markkinen S; Täll M; Raivio V; Turunen JA; Kivelä TT
    Hum Mol Genet; 2019 Jul; 28(14):2415-2426. PubMed ID: 31058963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.
    Zhang L; He X; Li F; Pan H; Huang X; Wen X; Zhang H; Li B; Ge S; Xu X; Jia R; Fan X
    J Exp Clin Cancer Res; 2018 Jan; 37(1):15. PubMed ID: 29382357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline BAP1 alterations in familial uveal melanoma.
    Rai K; Pilarski R; Boru G; Rehman M; Saqr AH; Massengill JB; Singh A; Marino MJ; Davidorf FH; Cebulla CM; H Abdel-Rahman M
    Genes Chromosomes Cancer; 2017 Feb; 56(2):168-174. PubMed ID: 27718540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome.
    Kashyap S; Jha J; Singh MK; Singh L; Sen S; Kaur J; Bajaj MS; Pushker N
    Clin Transl Oncol; 2020 Sep; 22(9):1472-1480. PubMed ID: 32124242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
    Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
    Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BAP1 loss augments sensitivity to BET inhibitors in cancer cells.
    Xu YY; Ren ZL; Liu XL; Zhang GM; Huang SS; Shi WH; Ye LX; Luo X; Liu SW; Li YL; Yu L
    Acta Pharmacol Sin; 2022 Jul; 43(7):1803-1815. PubMed ID: 34737422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma.
    Chua V; Han A; Bechtel N; Purwin TJ; Hunter E; Liao C; Harbour JW; Aplin AE
    Pigment Cell Melanoma Res; 2022 Jan; 35(1):78-87. PubMed ID: 34347929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic parameters in uveal melanoma and their association with BAP1 expression.
    van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ
    Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
    Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
    JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis.
    Szalai E; Wells JR; Ward L; Grossniklaus HE
    Ophthalmology; 2018 Feb; 125(2):203-209. PubMed ID: 28823399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19.
    Shahriyari L; Abdel-Rahman M; Cebulla C
    PLoS One; 2019; 14(2):e0211507. PubMed ID: 30716094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
    Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.
    Melzer C; Sharma A; Peters S; Aretz S; Biswas A; Holz FG; Loeffler KU; Herwig-Carl MC
    Genes Chromosomes Cancer; 2019 Jun; 58(6):357-364. PubMed ID: 30578689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma.
    Mergener S; Siveke JT; Peña-Llopis S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma.
    van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M
    Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma.
    Turunen JA; Markkinen S; Wilska R; Saarinen S; Raivio V; Täll M; Lehesjoki AE; Kivelä TT
    Ophthalmology; 2016 May; 123(5):1112-7. PubMed ID: 26876698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.
    Smit KN; van Poppelen NM; Vaarwater J; Verdijk R; van Marion R; Kalirai H; Coupland SE; Thornton S; Farquhar N; Dubbink HJ; Paridaens D; de Klein A; Kiliç E
    Mod Pathol; 2018 May; 31(5):763-771. PubMed ID: 29327717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ki67 is a better marker than PRAME in risk stratification of BAP1-positive and BAP1-loss uveal melanomas.
    Donizy P; Spytek M; Krzyziński M; Kotowski K; Markiewicz A; Romanowska-Dixon B; Biecek P; Hoang MP
    Br J Ophthalmol; 2024 Jun; 108(7):1005-1010. PubMed ID: 37734766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.